GSK’s pricing deal for Tyverb fails to sway NICE
October 15, 2008Sales and Marketing GSK, NICE, breast cancer
NICE has spurned GSK's risk-sharing proposal for its breast cancer treatment Tyverb, saying the drug is still too expensive to …
Oxford BioMedica fills leadership vacancy
October 14, 2008Research and Development, Sales and Marketing biotech
Oxford BioMedica has settled on a permanent chief executive, promoting John Dawson from his acting leadership position. Chairman professor Alan …
Pharma prepares for battle over EU patient information
October 14, 2008Sales and Marketing EU, patients, reform
A collective of European legislators, patient groups and the pharma industry have reiterated the call for Europe’s ban on pharma …
Johnson & Johnson appoints new global pharma chair
October 14, 2008Sales and Marketing JJ
Johnson & Johnson has named a new chairman for its struggling pharmaceuticals group, and kept the role under female leadership. …
Working Life: Dr Zubair Hussain
October 13, 2008Business Services, Research and Development, Sales and Marketing Pfizer, UK, careers, recruitment, reg affairs
How did you get into your current role After completing my D.Phil at Oxford, I looked for an opportunity in …
Latest news from Datamonitor
October 13, 2008Sales and Marketing HIV
Battle for HIV drug market share getting fiercerThe HIV market, worth $9.3 billion in 2007, is expected to grow to …
The Pharmafocus Interview: Jan Lundberg
October 10, 2008Research and Development AstraZeneca, clinical trials, drug discover
AstraZeneca's head of global drug discovery Jan Lundberg says his younger years as a sportsman have made him a determined …
Novartis pursues pulmonary hypertension indication for Glivec
October 10, 2008Sales and Marketing
Novartis says new data on Glivec shows it has potential to treat a life-threatening heart condition, despite failing to meet …
England’s mental health policy leading Europe, says WHO
October 10, 2008NHS, mental health
A new report from the World Health Organisation says England's mental health care has undergone a 'transformation' in the last …
A postcard from … Slovakia
October 10, 2008Research and Development, Sales and Marketing Europe, Slovakia, hc
UK is example to Europe on patient information, says industry
October 9, 2008Medical Communications patients
British pharma is free to provide necessary and sufficient information to patients about its drugs, and an example to be …
Lilly eyes oncology focus with ImClone acquisition
October 9, 2008Sales and Marketing Cancer, MA, lilly
Lilly is to buy ImClone for $6.5 billion after outbidding Bristol-Myers Squibb for the biotech company. Lilly says the acquisition …
GlycArt’s new cancer candidate to be developed with Roche
October 9, 2008Research and Development, Sales and Marketing GlycArt, Roche
Roche is to develop a potential cancer therapy with two business partners. Genentech, the Swiss biotech company GlycArt – wholly-owned …
Advertising start-up is UK’s ‘first virtual healthcare agency’
October 7, 2008Medical Communications digi
A new advertising agency has been launched as the UK’s first ‘virtual’ healthcare outfit, and aims to undercut traditional agencies …
Latest news from Datamonitor
October 6, 2008Sales and Marketing OTC
Is an Rx-to-OTC move the right prescription to protect pharma revenues and cut healthcare costs? The growing cost of developing …
GSK plans research job losses in UK
October 3, 2008Research and Development GSK, restructure
GlaxoSmithKline is set to cut about 850 jobs in early-stage research and development at sites across the world, including the …
Emerging confidence
October 2, 2008Research and Development, Sales and Marketing emerging markets, evidence-based medicine
The wisdom that emerging markets are vital to the pharmaceutical and biotechnology industry’s future has become a lot more conventional …
Osteoporosis drug Aclasta approved for use in men
October 2, 2008Sales and Marketing Novartis, aclasta, osteoporosis
Osteoporosis treatment Aclasta has been approved for an extended indication in the European Union.Novartis’ once-yearly infusion has now been given …
Latest content
